- Home
- OPT vs SMP Comparison
OPT vs SMP Comparison
Compare OPT & SMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- SMP
- Stock Information
- Founded
- OPT 1984
- SMP 1919
- Country
- OPT Australia
- SMP United States
- Employees
- OPT N/A
- SMP N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- SMP Auto Parts:O.E.M.
- Sector
- OPT Health Care
- SMP Consumer Discretionary
- Exchange
- OPT Nasdaq
- SMP Nasdaq
- Market Cap
- OPT 767.9M
- SMP 728.6M
- IPO Year
- OPT 2020
- SMP N/A
- Fundamental
- Price
- OPT $3.60
- SMP $31.35
- Analyst Decision
- OPT Strong Buy
- SMP Strong Buy
- Analyst Count
- OPT 1
- SMP 1
- Target Price
- OPT $12.00
- SMP $42.00
- AVG Volume (30 Days)
- OPT 9.2K
- SMP 115.1K
- Earning Date
- OPT 08-30-2024
- SMP 10-30-2024
- Dividend Yield
- OPT N/A
- SMP 3.71%
- EPS Growth
- OPT N/A
- SMP 1.17
- EPS
- OPT N/A
- SMP 1.63
- Revenue
- OPT $261,859.00
- SMP $1,411,253,000.00
- Revenue This Year
- OPT N/A
- SMP $5.58
- Revenue Next Year
- OPT $46,864.64
- SMP $2.30
- P/E Ratio
- OPT N/A
- SMP $19.18
- Revenue Growth
- OPT N/A
- SMP 2.58
- 52 Week Low
- OPT $1.79
- SMP $26.09
- 52 Week High
- OPT $5.45
- SMP $41.71
- Technical
- Relative Strength Index (RSI)
- OPT 52.65
- SMP 40.69
- Support Level
- OPT $3.15
- SMP $30.27
- Resistance Level
- OPT $3.39
- SMP $34.58
- Average True Range (ATR)
- OPT 0.17
- SMP 0.87
- MACD
- OPT 0.05
- SMP -0.32
- Stochastic Oscillator
- OPT 72.31
- SMP 25.06
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About SMP Standard Motor Products Inc.
Standard Motor Products Inc is a manufacturer and distributor of premium automotive parts used in the maintenance, service, and repair of vehicles in the automotive aftermarket industry. It operates into three business segments namely Engineered Solutions, Vehicle Control, and Temperature Control. The company focuses on the original equipment and original equipment services markets, with a product lineup of replacement parts for engine management ignition, emission, and fuel systems, as well as temperature-control products. The company operates majorly in the United States, with additional sales in Canada, Europe, Asia, Mexico, and other Latin American countries.